Report cover image

Beraprost Sodium Industry Research Report 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 137 Pages
SKU # APRC20543475

Description

Summary

According to APO Research, the global Beraprost Sodium market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Beraprost Sodium is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Beraprost Sodium is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Beraprost Sodium is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Beraprost Sodium include Teva, Daiichi Sankyo Co Ltd, Yoshindo, Viatris, Toray, Taide Pharma, Shin Poong Pharmaceutical, Sawai Pharmaceutical and Ohara Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Beraprost Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beraprost Sodium.

The report will help the Beraprost Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Beraprost Sodium market size, estimations, and forecasts are provided in terms of sales volume (k pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Beraprost Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Beraprost Sodium Segment by Company
Teva Daiichi Sankyo Co Ltd Yoshindo Viatris Toray Taide Pharma Shin Poong Pharmaceutical Sawai Pharmaceutical Ohara Inc Nihon Generic Co Ltd Nichiiko NABIQASIM INDUSTRIES Lupin Laboratories KYOUSOUMIRAI PHARM Kyorin Holding Kaken Pharmaceutical Astellas Pharma Alfresa PharmaBeraprost Sodium Segment by Type
Tablet Sustained Release TabletsBeraprost Sodium Segment by Application
Hospital ClinicBeraprost Sodium Segment by Region
North America United States Canada Mexico Europe Germany France U.K. Italy Russia Spain Netherlands Switzerland Sweden Poland Asia-Pacific China Japan South Korea India Australia Taiwan Southeast Asia South America Brazil Argentina Chile Middle East & Africa Egypt South Africa Israel Türkiye GCC Countries

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Beraprost Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Beraprost Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Beraprost Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Beraprost Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Beraprost Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Beraprost Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Table of Contents

137 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Beraprost Sodium Market Size (2020-2031)
2.2.2 Global Beraprost Sodium Sales (2020-2031)
2.2.3 Global Beraprost Sodium Market Average Price (2020-2031)
2.3 Beraprost Sodium by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Tablet
2.3.3 Sustained Release Tablets
2.4 Beraprost Sodium by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Hospital
2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
3.1 Global Beraprost Sodium Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Beraprost Sodium Sales (k pcs) of Manufacturers (2020-2025)
3.3 Global Beraprost Sodium Revenue of Manufacturers (2020-2025)
3.4 Global Beraprost Sodium Average Price by Manufacturers (2020-2025)
3.5 Global Beraprost Sodium Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Beraprost Sodium, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Beraprost Sodium, Product Type & Application
3.8 Global Manufacturers of Beraprost Sodium, Established Date
3.9 Global Beraprost Sodium Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Teva
4.1.1 Teva Company Information
4.1.2 Teva Business Overview
4.1.3 Teva Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Teva Beraprost Sodium Product Portfolio
4.1.5 Teva Recent Developments
4.2 Daiichi Sankyo Co Ltd
4.2.1 Daiichi Sankyo Co Ltd Company Information
4.2.2 Daiichi Sankyo Co Ltd Business Overview
4.2.3 Daiichi Sankyo Co Ltd Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Daiichi Sankyo Co Ltd Beraprost Sodium Product Portfolio
4.2.5 Daiichi Sankyo Co Ltd Recent Developments
4.3 Yoshindo
4.3.1 Yoshindo Company Information
4.3.2 Yoshindo Business Overview
4.3.3 Yoshindo Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Yoshindo Beraprost Sodium Product Portfolio
4.3.5 Yoshindo Recent Developments
4.4 Viatris
4.4.1 Viatris Company Information
4.4.2 Viatris Business Overview
4.4.3 Viatris Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Viatris Beraprost Sodium Product Portfolio
4.4.5 Viatris Recent Developments
4.5 Toray
4.5.1 Toray Company Information
4.5.2 Toray Business Overview
4.5.3 Toray Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Toray Beraprost Sodium Product Portfolio
4.5.5 Toray Recent Developments
4.6 Taide Pharma
4.6.1 Taide Pharma Company Information
4.6.2 Taide Pharma Business Overview
4.6.3 Taide Pharma Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Taide Pharma Beraprost Sodium Product Portfolio
4.6.5 Taide Pharma Recent Developments
4.7 Shin Poong Pharmaceutical
4.7.1 Shin Poong Pharmaceutical Company Information
4.7.2 Shin Poong Pharmaceutical Business Overview
4.7.3 Shin Poong Pharmaceutical Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Shin Poong Pharmaceutical Beraprost Sodium Product Portfolio
4.7.5 Shin Poong Pharmaceutical Recent Developments
4.8 Sawai Pharmaceutical
4.8.1 Sawai Pharmaceutical Company Information
4.8.2 Sawai Pharmaceutical Business Overview
4.8.3 Sawai Pharmaceutical Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Sawai Pharmaceutical Beraprost Sodium Product Portfolio
4.8.5 Sawai Pharmaceutical Recent Developments
4.9 Ohara Inc
4.9.1 Ohara Inc Company Information
4.9.2 Ohara Inc Business Overview
4.9.3 Ohara Inc Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Ohara Inc Beraprost Sodium Product Portfolio
4.9.5 Ohara Inc Recent Developments
4.10 Nihon Generic Co Ltd
4.10.1 Nihon Generic Co Ltd Company Information
4.10.2 Nihon Generic Co Ltd Business Overview
4.10.3 Nihon Generic Co Ltd Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Nihon Generic Co Ltd Beraprost Sodium Product Portfolio
4.10.5 Nihon Generic Co Ltd Recent Developments
4.11 Nichiiko
4.11.1 Nichiiko Company Information
4.11.2 Nichiiko Business Overview
4.11.3 Nichiiko Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Nichiiko Beraprost Sodium Product Portfolio
4.11.5 Nichiiko Recent Developments
4.12 NABIQASIM INDUSTRIES
4.12.1 NABIQASIM INDUSTRIES Company Information
4.12.2 NABIQASIM INDUSTRIES Business Overview
4.12.3 NABIQASIM INDUSTRIES Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.12.4 NABIQASIM INDUSTRIES Beraprost Sodium Product Portfolio
4.12.5 NABIQASIM INDUSTRIES Recent Developments
4.13 Lupin Laboratories
4.13.1 Lupin Laboratories Company Information
4.13.2 Lupin Laboratories Business Overview
4.13.3 Lupin Laboratories Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Lupin Laboratories Beraprost Sodium Product Portfolio
4.13.5 Lupin Laboratories Recent Developments
4.14 KYOUSOUMIRAI PHARM
4.14.1 KYOUSOUMIRAI PHARM Company Information
4.14.2 KYOUSOUMIRAI PHARM Business Overview
4.14.3 KYOUSOUMIRAI PHARM Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.14.4 KYOUSOUMIRAI PHARM Beraprost Sodium Product Portfolio
4.14.5 KYOUSOUMIRAI PHARM Recent Developments
4.15 Kyorin Holding
4.15.1 Kyorin Holding Company Information
4.15.2 Kyorin Holding Business Overview
4.15.3 Kyorin Holding Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.15.4 Kyorin Holding Beraprost Sodium Product Portfolio
4.15.5 Kyorin Holding Recent Developments
4.16 Kaken Pharmaceutical
4.16.1 Kaken Pharmaceutical Company Information
4.16.2 Kaken Pharmaceutical Business Overview
4.16.3 Kaken Pharmaceutical Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.16.4 Kaken Pharmaceutical Beraprost Sodium Product Portfolio
4.16.5 Kaken Pharmaceutical Recent Developments
4.17 Astellas Pharma
4.17.1 Astellas Pharma Company Information
4.17.2 Astellas Pharma Business Overview
4.17.3 Astellas Pharma Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.17.4 Astellas Pharma Beraprost Sodium Product Portfolio
4.17.5 Astellas Pharma Recent Developments
4.18 Alfresa Pharma
4.18.1 Alfresa Pharma Company Information
4.18.2 Alfresa Pharma Business Overview
4.18.3 Alfresa Pharma Beraprost Sodium Sales, Revenue and Gross Margin (2020-2025)
4.18.4 Alfresa Pharma Beraprost Sodium Product Portfolio
4.18.5 Alfresa Pharma Recent Developments
5 Global Beraprost Sodium Market Scenario by Region
5.1 Global Beraprost Sodium Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Beraprost Sodium Sales by Region: 2020-2031
5.2.1 Global Beraprost Sodium Sales by Region: 2020-2025
5.2.2 Global Beraprost Sodium Sales by Region: 2026-2031
5.3 Global Beraprost Sodium Revenue by Region: 2020-2031
5.3.1 Global Beraprost Sodium Revenue by Region: 2020-2025
5.3.2 Global Beraprost Sodium Revenue by Region: 2026-2031
5.4 North America Beraprost Sodium Market Facts & Figures by Country
5.4.1 North America Beraprost Sodium Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Beraprost Sodium Sales by Country (2020-2031)
5.4.3 North America Beraprost Sodium Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Beraprost Sodium Market Facts & Figures by Country
5.5.1 Europe Beraprost Sodium Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Beraprost Sodium Sales by Country (2020-2031)
5.5.3 Europe Beraprost Sodium Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Beraprost Sodium Market Facts & Figures by Country
5.6.1 Asia Pacific Beraprost Sodium Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Beraprost Sodium Sales by Country (2020-2031)
5.6.3 Asia Pacific Beraprost Sodium Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Beraprost Sodium Market Facts & Figures by Country
5.7.1 South America Beraprost Sodium Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Beraprost Sodium Sales by Country (2020-2031)
5.7.3 South America Beraprost Sodium Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Beraprost Sodium Market Facts & Figures by Country
5.8.1 Middle East and Africa Beraprost Sodium Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Beraprost Sodium Sales by Country (2020-2031)
5.8.3 Middle East and Africa Beraprost Sodium Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Beraprost Sodium Sales by Type (2020-2031)
6.1.1 Global Beraprost Sodium Sales by Type (2020-2031) & (k pcs)
6.1.2 Global Beraprost Sodium Sales Market Share by Type (2020-2031)
6.2 Global Beraprost Sodium Revenue by Type (2020-2031)
6.2.1 Global Beraprost Sodium Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Beraprost Sodium Revenue Market Share by Type (2020-2031)
6.3 Global Beraprost Sodium Price by Type (2020-2031)
7 Segment by Application
7.1 Global Beraprost Sodium Sales by Application (2020-2031)
7.1.1 Global Beraprost Sodium Sales by Application (2020-2031) & (k pcs)
7.1.2 Global Beraprost Sodium Sales Market Share by Application (2020-2031)
7.2 Global Beraprost Sodium Revenue by Application (2020-2031)
7.2.1 Global Beraprost Sodium Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Beraprost Sodium Revenue Market Share by Application (2020-2031)
7.3 Global Beraprost Sodium Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Beraprost Sodium Value Chain Analysis
8.1.1 Beraprost Sodium Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Beraprost Sodium Production Mode & Process
8.2 Beraprost Sodium Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Beraprost Sodium Distributors
8.2.3 Beraprost Sodium Customers
9 Global Beraprost Sodium Analyzing Market Dynamics
9.1 Beraprost Sodium Industry Trends
9.2 Beraprost Sodium Industry Drivers
9.3 Beraprost Sodium Industry Opportunities and Challenges
9.4 Beraprost Sodium Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
Table 5. Global Beraprost Sodium Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
Table 6. Global Beraprost Sodium Sales (k pcs) of Manufacturers (2020-2025)
Table 7. Global Beraprost Sodium Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Beraprost Sodium Revenue of Manufacturers (2020-2025)
Table 9. Global Beraprost Sodium Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Beraprost Sodium Average Price (US$/pcs) of Manufacturers (2020-2025)
Table 11. Global Beraprost Sodium Industry Ranking, 2023 VS 2024 VS 2025
Table 12. Global Manufacturers of Beraprost Sodium, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Beraprost Sodium, Product Type & Application
Table 14. Global Beraprost Sodium Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Beraprost Sodium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Teva Company Information
Table 19. Teva Business Overview
Table 20. Teva Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 21. Teva Beraprost Sodium Product Portfolio
Table 22. Teva Recent Developments
Table 23. Daiichi Sankyo Co Ltd Company Information
Table 24. Daiichi Sankyo Co Ltd Business Overview
Table 25. Daiichi Sankyo Co Ltd Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 26. Daiichi Sankyo Co Ltd Beraprost Sodium Product Portfolio
Table 27. Daiichi Sankyo Co Ltd Recent Developments
Table 28. Yoshindo Company Information
Table 29. Yoshindo Business Overview
Table 30. Yoshindo Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 31. Yoshindo Beraprost Sodium Product Portfolio
Table 32. Yoshindo Recent Developments
Table 33. Viatris Company Information
Table 34. Viatris Business Overview
Table 35. Viatris Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 36. Viatris Beraprost Sodium Product Portfolio
Table 37. Viatris Recent Developments
Table 38. Toray Company Information
Table 39. Toray Business Overview
Table 40. Toray Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 41. Toray Beraprost Sodium Product Portfolio
Table 42. Toray Recent Developments
Table 43. Taide Pharma Company Information
Table 44. Taide Pharma Business Overview
Table 45. Taide Pharma Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 46. Taide Pharma Beraprost Sodium Product Portfolio
Table 47. Taide Pharma Recent Developments
Table 48. Shin Poong Pharmaceutical Company Information
Table 49. Shin Poong Pharmaceutical Business Overview
Table 50. Shin Poong Pharmaceutical Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 51. Shin Poong Pharmaceutical Beraprost Sodium Product Portfolio
Table 52. Shin Poong Pharmaceutical Recent Developments
Table 53. Sawai Pharmaceutical Company Information
Table 54. Sawai Pharmaceutical Business Overview
Table 55. Sawai Pharmaceutical Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 56. Sawai Pharmaceutical Beraprost Sodium Product Portfolio
Table 57. Sawai Pharmaceutical Recent Developments
Table 58. Ohara Inc Company Information
Table 59. Ohara Inc Business Overview
Table 60. Ohara Inc Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 61. Ohara Inc Beraprost Sodium Product Portfolio
Table 62. Ohara Inc Recent Developments
Table 63. Nihon Generic Co Ltd Company Information
Table 64. Nihon Generic Co Ltd Business Overview
Table 65. Nihon Generic Co Ltd Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 66. Nihon Generic Co Ltd Beraprost Sodium Product Portfolio
Table 67. Nihon Generic Co Ltd Recent Developments
Table 68. Nichiiko Company Information
Table 69. Nichiiko Business Overview
Table 70. Nichiiko Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 71. Nichiiko Beraprost Sodium Product Portfolio
Table 72. Nichiiko Recent Developments
Table 73. NABIQASIM INDUSTRIES Company Information
Table 74. NABIQASIM INDUSTRIES Business Overview
Table 75. NABIQASIM INDUSTRIES Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 76. NABIQASIM INDUSTRIES Beraprost Sodium Product Portfolio
Table 77. NABIQASIM INDUSTRIES Recent Developments
Table 78. Lupin Laboratories Company Information
Table 79. Lupin Laboratories Business Overview
Table 80. Lupin Laboratories Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 81. Lupin Laboratories Beraprost Sodium Product Portfolio
Table 82. Lupin Laboratories Recent Developments
Table 83. KYOUSOUMIRAI PHARM Company Information
Table 84. KYOUSOUMIRAI PHARM Business Overview
Table 85. KYOUSOUMIRAI PHARM Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 86. KYOUSOUMIRAI PHARM Beraprost Sodium Product Portfolio
Table 87. KYOUSOUMIRAI PHARM Recent Developments
Table 88. Kyorin Holding Company Information
Table 89. Kyorin Holding Business Overview
Table 90. Kyorin Holding Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 91. Kyorin Holding Beraprost Sodium Product Portfolio
Table 92. Kyorin Holding Recent Developments
Table 93. Kaken Pharmaceutical Company Information
Table 94. Kaken Pharmaceutical Business Overview
Table 95. Kaken Pharmaceutical Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 96. Kaken Pharmaceutical Beraprost Sodium Product Portfolio
Table 97. Kaken Pharmaceutical Recent Developments
Table 98. Astellas Pharma Company Information
Table 99. Astellas Pharma Business Overview
Table 100. Astellas Pharma Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 101. Astellas Pharma Beraprost Sodium Product Portfolio
Table 102. Astellas Pharma Recent Developments
Table 103. Alfresa Pharma Company Information
Table 104. Alfresa Pharma Business Overview
Table 105. Alfresa Pharma Beraprost Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
Table 106. Alfresa Pharma Beraprost Sodium Product Portfolio
Table 107. Alfresa Pharma Recent Developments
Table 108. Global Beraprost Sodium Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 109. Global Beraprost Sodium Sales by Region (2020-2025) & (k pcs)
Table 110. Global Beraprost Sodium Sales Market Share by Region (2020-2025)
Table 111. Global Beraprost Sodium Sales by Region (2026-2031) & (k pcs)
Table 112. Global Beraprost Sodium Sales Market Share by Region (2026-2031)
Table 113. Global Beraprost Sodium Revenue by Region (2020-2025) & (US$ Million)
Table 114. Global Beraprost Sodium Revenue Market Share by Region (2020-2025)
Table 115. Global Beraprost Sodium Revenue by Region (2026-2031) & (US$ Million)
Table 116. Global Beraprost Sodium Revenue Market Share by Region (2026-2031)
Table 117. North America Beraprost Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 118. North America Beraprost Sodium Sales by Country (2020-2025) & (k pcs)
Table 119. North America Beraprost Sodium Sales by Country (2026-2031) & (k pcs)
Table 120. North America Beraprost Sodium Revenue by Country (2020-2025) & (US$ Million)
Table 121. North America Beraprost Sodium Revenue by Country (2026-2031) & (US$ Million)
Table 122. Europe Beraprost Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 123. Europe Beraprost Sodium Sales by Country (2020-2025) & (k pcs)
Table 124. Europe Beraprost Sodium Sales by Country (2026-2031) & (k pcs)
Table 125. Europe Beraprost Sodium Revenue by Country (2020-2025) & (US$ Million)
Table 126. Europe Beraprost Sodium Revenue by Country (2026-2031) & (US$ Million)
Table 127. Asia Pacific Beraprost Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 128. Asia Pacific Beraprost Sodium Sales by Country (2020-2025) & (k pcs)
Table 129. Asia Pacific Beraprost Sodium Sales by Country (2026-2031) & (k pcs)
Table 130. Asia Pacific Beraprost Sodium Revenue by Country (2020-2025) & (US$ Million)
Table 131. Asia Pacific Beraprost Sodium Revenue by Country (2026-2031) & (US$ Million)
Table 132. South America Beraprost Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 133. South America Beraprost Sodium Sales by Country (2020-2025) & (k pcs)
Table 134. South America Beraprost Sodium Sales by Country (2026-2031) & (k pcs)
Table 135. South America Beraprost Sodium Revenue by Country (2020-2025) & (US$ Million)
Table 136. South America Beraprost Sodium Revenue by Country (2026-2031) & (US$ Million)
Table 137. Middle East and Africa Beraprost Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 138. Middle East and Africa Beraprost Sodium Sales by Country (2020-2025) & (k pcs)
Table 139. Middle East and Africa Beraprost Sodium Sales by Country (2026-2031) & (k pcs)
Table 140. Middle East and Africa Beraprost Sodium Revenue by Country (2020-2025) & (US$ Million)
Table 141. Middle East and Africa Beraprost Sodium Revenue by Country (2026-2031) & (US$ Million)
Table 142. Global Beraprost Sodium Sales by Type (2020-2025) & (k pcs)
Table 143. Global Beraprost Sodium Sales by Type (2026-2031) & (k pcs)
Table 144. Global Beraprost Sodium Sales Market Share by Type (2020-2025)
Table 145. Global Beraprost Sodium Sales Market Share by Type (2026-2031)
Table 146. Global Beraprost Sodium Revenue by Type (2020-2025) & (US$ Million)
Table 147. Global Beraprost Sodium Revenue by Type (2026-2031) & (US$ Million)
Table 148. Global Beraprost Sodium Revenue Market Share by Type (2020-2025)
Table 149. Global Beraprost Sodium Revenue Market Share by Type (2026-2031)
Table 150. Global Beraprost Sodium Price by Type (2020-2025) & (US$/pcs)
Table 151. Global Beraprost Sodium Price by Type (2026-2031) & (US$/pcs)
Table 152. Global Beraprost Sodium Sales by Application (2020-2025) & (k pcs)
Table 153. Global Beraprost Sodium Sales by Application (2026-2031) & (k pcs)
Table 154. Global Beraprost Sodium Sales Market Share by Application (2020-2025)
Table 155. Global Beraprost Sodium Sales Market Share by Application (2026-2031)
Table 156. Global Beraprost Sodium Revenue by Application (2020-2025) & (US$ Million)
Table 157. Global Beraprost Sodium Revenue by Application (2026-2031) & (US$ Million)
Table 158. Global Beraprost Sodium Revenue Market Share by Application (2020-2025)
Table 159. Global Beraprost Sodium Revenue Market Share by Application (2026-2031)
Table 160. Global Beraprost Sodium Price by Application (2020-2025) & (US$/pcs)
Table 161. Global Beraprost Sodium Price by Application (2026-2031) & (US$/pcs)
Table 162. Key Raw Materials
Table 163. Raw Materials Key Suppliers
Table 164. Beraprost Sodium Distributors List
Table 165. Beraprost Sodium Customers List
Table 166. Beraprost Sodium Industry Trends
Table 167. Beraprost Sodium Industry Drivers
Table 168. Beraprost Sodium Industry Restraints
Table 169. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Beraprost Sodium Product Image
Figure 5. Global Beraprost Sodium Revenue (US$ Million), 2020 VS 2024 VS 2031
Figure 6. Global Beraprost Sodium Market Size (2020-2031) & (US$ Million)
Figure 7. Global Beraprost Sodium Sales (2020-2031) & (k pcs)
Figure 8. Global Beraprost Sodium Average Price (US$/pcs) & (2020-2031)
Figure 9. Tablet Product Image
Figure 10. Sustained Release Tablets Product Image
Figure 11. Hospital Product Image
Figure 12. Clinic Product Image
Figure 13. Global Beraprost Sodium Revenue Share by Manufacturers in 2024
Figure 14. Global Manufacturers of Beraprost Sodium, Manufacturing Sites & Headquarters
Figure 15. Global Top 5 and 10 Beraprost Sodium Players Market Share by Revenue in 2024
Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 17. Global Beraprost Sodium Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 18. Global Beraprost Sodium Sales by Region in 2024
Figure 19. Global Beraprost Sodium Revenue by Region in 2024
Figure 20. North America Beraprost Sodium Market Size by Country in 2024
Figure 21. North America Beraprost Sodium Sales Market Share by Country (2020-2031)
Figure 22. North America Beraprost Sodium Revenue Market Share by Country (2020-2031)
Figure 23. United States Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Mexico Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Beraprost Sodium Market Size by Country in 2024
Figure 27. Europe Beraprost Sodium Sales Market Share by Country (2020-2031)
Figure 28. Europe Beraprost Sodium Revenue Market Share by Country (2020-2031)
Figure 29. Germany Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Spain Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Netherlands Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Switzerland Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Sweden Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Poland Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Asia Pacific Beraprost Sodium Market Size by Country in 2024
Figure 40. Asia Pacific Beraprost Sodium Sales Market Share by Country (2020-2031)
Figure 41. Asia Pacific Beraprost Sodium Revenue Market Share by Country (2020-2031)
Figure 42. China Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Japan Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. South Korea Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. India Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Australia Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Taiwan Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Southeast Asia Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Southeast Asia Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. South America Beraprost Sodium Market Size by Country in 2024
Figure 51. South America Beraprost Sodium Sales Market Share by Country (2020-2031)
Figure 52. South America Beraprost Sodium Revenue Market Share by Country (2020-2031)
Figure 53. Brazil Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Argentina Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Chile Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Beraprost Sodium Market Size by Country in 2024
Figure 57. Middle East and Africa Beraprost Sodium Sales Market Share by Country (2020-2031)
Figure 58. Middle East and Africa Beraprost Sodium Revenue Market Share by Country (2020-2031)
Figure 59. Egypt Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. South Africa Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. Israel Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 62. Türkiye Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 63. GCC Countries Beraprost Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 64. Global Beraprost Sodium Sales Market Share by Type (2020-2031)
Figure 65. Global Beraprost Sodium Revenue Market Share by Type (2020-2031)
Figure 66. Global Beraprost Sodium Price (US$/pcs) by Type (2020-2031)
Figure 67. Global Beraprost Sodium Sales Market Share by Application (2020-2031)
Figure 68. Global Beraprost Sodium Revenue Market Share by Application (2020-2031)
Figure 69. Global Beraprost Sodium Price (US$/pcs) by Application (2020-2031)
Figure 70. Beraprost Sodium Value Chain
Figure 71. Beraprost Sodium Production Mode & Process
Figure 72. Direct Comparison with Distribution Share
Figure 73. Distributors Profiles
Figure 74. Beraprost Sodium Industry Opportunities and Challenges
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.